ReviewOncoTargets and therapy2017

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.

Benjamin S Gerendash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.